"LM_ID"	"COMMON_NAME"	"SYSTEMATIC_NAME"	"FORMULA"	"MASS"	"CATEGORY"	"MAIN_CLASS"	"SUB_CLASS"	"CLASS_LEVEL4"	"SYNONYMS"	"INCHI_KEY"	"INCHI"	"SMILES"	"KEGG_ID"	"HMDBID"	"CHEBI_ID"	"ABBREVIATION"	"PUBCHEM_COMPOUND_ID"	"LIPIDBANK_ID"	"SWISSLIPIDS_ID"	"CAYMAN_ID"	"ALT_CATEGORIES"	"ALT_MAIN_CLASSES"	"ALT_SUB_CLASSES"	"ALT_CLASS_LEVEL4S"	"TAXONOMY"	"CITATION"
"LMSP0505AE07"	"type II B antigen(d18:1/24:1(15Z))"	"Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))"	"C80H144N2O32"	"1644.97023"	"Sphingolipids [SP]"	"Neutral glycosphingolipids [SP05]"	"Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]"	"-"	"-"	"DLMCNWQZVCFJLX-RAKAQLQESA-N"	"InChI=1S/C80H144N2O32/c1-5-7-9-11-13-15-17-19-20-21-22-23-24-25-26-28-30-32-34-36-38-40-56(90)82-49(50(89)39-37-35-33-31-29-27-18-16-14-12-10-8-6-2)46-103-76-68(101)65(98)71(55(45-87)109-76)110-79-69(102)72(60(93)52(42-84)106-79)112-75-57(81-48(4)88)62(95)70(54(44-86)108-75)111-80-74(114-77-66(99)63(96)58(91)47(3)104-77)73(61(94)53(43-85)107-80)113-78-67(100)64(97)59(92)51(41-83)105-78/h19-20,37,39,47,49-55,57-80,83-87,89,91-102H,5-18,21-36,38,40-46H2,1-4H3,(H,81,88)(H,82,90)/b20-19-,39-37+/t47-,49+,50-,51-,52-,53-,54-,55-,57-,58-,59+,60+,61+,62-,63-,64+,65-,66+,67-,68-,69-,70-,71-,72+,73+,74-,75+,76-,77-,78-,79+,80+/m1/s1"	"[C@](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5O)[C@H]4O[C@H]4O[C@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(=O)C)[C@H]2O)[C@H](O)[C@H]1O)([H])(NC(CCCCCCCCCCCCC/C=C\CCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC"	"-"	"-"	"-"	"Hex(4)-HexNAc-Fuc-Cer 42:2;O2"	"44261010"	"-"	"-"	"-"	"-"	"-"	"-"	"-"	"-"	"-"